Abstract
The recent explosion in the number and diversity of non-coding RNAs (ncRNAs) identified by the large-scale technologies brings new challenges to the biomedical researchers – What are all these non-coding RNAs, how did they work, and most importantly, what is the relationship between them and complex diseases? Although some ncRNAs have been clearly characterized as risk biomarkers through biological experiments, there are still a limit number of known disease associated ncRNAs. Thus, bioinformatics methods have been widely used to predict candidate ncRNAs and disease associations. In this chapter, we will discuss several bioinformatics methods which have been developed to predict novel non-coding biomarkers. With such methods and tools, the prioritization and identification of complex-implicated ncRNAs is becoming a reality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233
Wilusz JE, Sunwoo H, Spector DL (2009) Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 23:1494–1504
Ning S, Gao Y, Wang P, Li X, Zhi H, Zhang Y, Liu Y, Zhang J, Guo M, Han D, Li X (2016) Construction of a lncRNA-mediated feed-forward loop network reveals global topological features and prognostic motifs in human cancers. Oncotarget 7:45937–45947
Ponting CP, Oliver PL, Reik W (2009) Evolution and functions of long noncoding RNAs. Cell 136:629–641
Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, Ansell PJ, Zhao J, Weng C, Klibanski A (2007) Activation of p53 by MEG3 non-coding RNA. J Biol Chem 282:24731–24742
Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ (2006) The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 66:5330–5337
Li Y, Qiu C, Tu J, Geng B, Yang J, Jiang T, Cui Q (2014) HMDD v2.0: a database for experimentally supported human microRNA and disease associations. Nucleic Acids Res 42:D1070–D1074
Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen X, Zhang Q, Yan G, Cui Q (2013) LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res 41:D983–D986
Ning S, Zhang J, Wang P, Zhi H, Wang J, Liu Y, Gao Y, Guo M, Yue M, Wang L, Li X (2016) Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers. Nucleic Acids Res 44:D980–D985
Zhao Z, Bai J, Wu A, Wang Y, Zhang J, Wang Z, Li Y, Xu J Li X (2015) Co-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-Seq data. Database (Oxford); 2015:1–7
Aranda B, Blankenburg H, Kerrien S, Brinkman FS, Ceol A, Chautard E, Dana JM, De Las Rivas J, Dumousseau M, Galeota E, Gaulton A, Goll J, Hancock RE, Isserlin R, Jimenez RC, Kerssemakers J, Khadake J, Lynn DJ, Michaut M, O’Kelly G, Ono K, Orchard S, Prieto C, Razick S, Rigina O, Salwinski L, Simonovic M, Velankar S, Winter A, Wu G, Bader GD, Cesareni G, Donaldson IM, Eisenberg D, Kleywegt GJ, Overington J, Ricard-Blum S, Tyers M, Albrecht M, Hermjakob H (2011) PSICQUIC and PSISCORE: accessing and scoring molecular interactions. Nat Methods 8:528–529
Wang P, Ning S, Zhang Y, Li R, Ye J, Zhao Z, Zhi H, Wang T, Guo Z, Li X (2015) Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancer. Nucleic Acids Res 43:3478–3489
Guo Q, Cheng Y, Liang T, He Y, Ren C, Sun L, Zhang G (2015) Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression. Sci Rep 5:17683
Guo X, Gao L, Liao Q, Xiao H, Ma X, Yang X, Luo H, Zhao G, Bu D, Jiao F, Shao Q, Chen R, Zhao Y (2013) Long non-coding RNAs function annotation: a global prediction method based on bi-colored networks. Nucleic Acids Res 41:e35
Yang X, Gao L, Guo X, Shi X, Wu H, Song F, Wang B (2014) A network based method for analysis of lncRNA-disease associations and prediction of lncRNAs implicated in diseases. PLoS One 9:e87797
Doncheva NT, Kacprowski T, Albrecht M (2012) Recent approaches to the prioritization of candidate disease genes. Wiley Interdiscip Rev Syst Biol Med 4:429–442
Wang P, Guo Q, Gao Y, Zhi H, Zhang Y, Liu Y, Zhang J, Yue M, Guo M, Ning S, Zhang G, Li X (2017) Improved method for prioritization of disease associated lncRNAs based on ceRNA theory and functional genomics data. Oncotarget 8:4642–4655
Zhou M, Wang X, Li J, Hao D, Wang Z, Shi H, Han L, Zhou H, Sun J (2015) Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network. Mol BioSyst 11:760–769
Jiang Q, Hao Y, Wang G, Juan L, Zhang T, Teng M, Liu Y, Wang Y (2010) Prioritization of disease microRNAs through a human phenome-microRNAome network. BMC Syst Biol 4(Suppl 1):S2
Xu C, Qi R, Ping Y, Li J, Zhao H, Wang L, Du MY, Xiao Y, Li X (2017) Systemically identifying and prioritizing risk lncRNAs through integration of pan-cancer phenotype associations. Oncotarget 8:12041–12051
van Laarhoven T, Nabuurs SB, Marchiori E (2011) Gaussian interaction profile kernels for predicting drug-target interaction. Bioinformatics 27:3036–3043
Tranchevent LC, Barriot R, Yu S, Van Vooren S, Van Loo P, Coessens B, De Moor B, Aerts S, Moreau Y (2008) ENDEAVOUR update: a web resource for gene prioritization in multiple species. Nucleic Acids Res 36:W377–W384
Xiao Y, Guan J, Ping Y, Xu C, Huang T, Zhao H, Fan H, Li Y, Lv Y, Zhao T, Dong Y, Ren H, Li X (2012) Prioritizing cancer-related key miRNA-target interactions by integrative genomics. Nucleic Acids Res 40:7653–7665
Aerts S, Lambrechts D, Maity S, Van Loo P, Coessens B, De Smet F, Tranchevent LC, De Moor B, Marynen P, Hassan B, Carmeliet P, Moreau Y (2006) Gene prioritization through genomic data fusion. Nat Biotechnol 24:537–544
Sifrim A, Popovic D, Tranchevent LC, Ardeshirdavani A, Sakai R, Konings P, Vermeesch JR, Aerts J, De Moor B, Moreau Y (2013) eXtasy: variant prioritization by genomic data fusion. Nat Methods 10:1083–1084
Wang P, Ning S, Wang Q, Li R, Ye J, Zhao Z, Li Y, Huang T, Li X (2013) mirTarPri: improved prioritization of microRNA targets through incorporation of functional genomics data. PLoS One 8:e53685
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wang, P., Li, X. (2018). Genomic-Scale Prioritization of Disease-Related Non-coding RNAs. In: Li, X., Xu, J., Xiao, Y., Ning, S., Zhang, Y. (eds) Non-coding RNAs in Complex Diseases. Advances in Experimental Medicine and Biology, vol 1094. Springer, Singapore. https://doi.org/10.1007/978-981-13-0719-5_4
Download citation
DOI: https://doi.org/10.1007/978-981-13-0719-5_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0718-8
Online ISBN: 978-981-13-0719-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)